Evaluation of Benzophenone-N-ethyl Morpholine Ethers as Antibacterial and Antifungal Activities

Table 3

MIC (μg/mL) of compounds 5a–j against tested bacteria.

Compounds	Minimum inhibitory concentration (𝜇g/ mL)
	Gram-positive bacteria				Gram-negative bacteria
	S. aureus	S. aureus  (MRSA)	E. aerogenes	M. luteus	K. pneumoniae	S. typhimurium	S. Paratyphi-B	P. vulgaris
5c	250	500	250	250	500	62.5	500	500
5d	31.25	125	125	63.5	63.5	250	125	250
5e	31.25	62.5	15.62	15.62	15.62	15.62	125	<15.62
5f	15.62	12.5	62.5	12.5	250	15.62	500	125
5g	15.62	250	250	32.5	250	31.25	500	62.5
5h	15.62	250	62.5	62.5	550	31.25	500	125
5i	62.5	500	500	250	250	125	500	500
Streptomycin	6.25	>100	25	6.25	6.25	30	ni	6.25
Ciprofloxacin	<0.78	>100	<0.78	>100	<0.78	>100	6.25	<0.78

ni: no inhibition.